Tevogen Bio Holdings Inc. (TVGN) — Financial statements
Income statement, balance sheet, and cash flow for Tevogen Bio Holdings Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.51↑26.2% | 0.40↑6.7% | 0.38 | 0.00 | 0.00 | |
| Gross Profit | -0.51↓26.2% | -0.40↓6.7% | -0.38 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 11↓64.2% | 31↑604.7% | 4 | 0.00↓100.0% | 3 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 2 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 15↓34.4% | 22↑444.9% | 4↑326.1% | 0.95↓42.7% | 2 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 26↓51.8% | 53↑528.0% | 8↑788.1% | 0.95↓79.4% | 5 | |
| Total Costs & Expenses | 26↓51.2% | 54↑505.7% | 9↑827.8% | 0.95↓79.4% | 5 | |
| Operating Results | ||||||
| Operating Income | -26↑51.2% | -54↓505.7% | -9↓827.8% | -0.95↑79.4% | -5 | |
| Depreciation & Amortization | 0.51↑26.2% | 0.40↑6.7% | 0.38 | 0.00↓100.0% | 0.01 | |
| EBITDA | -26↓95.1% | -13↑77.7% | -59↓1435.9% | 4↑129.4% | -15 | |
| EBIT | -26↓93.0% | -14↑77.2% | -59↓1444.5% | 4↑129.4% | -15 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.20↓6.3% | -0.18↑28.1% | -0.26 | 0.00↑100.0% | -0.60 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.20↑6.3% | 0.18↓28.1% | 0.26 | 0.00↓100.0% | 0.60 | |
| Non-Operating Income | -0.06↑99.8% | -40↓179.4% | 50↑1040.6% | -5↓151.7% | 10 | |
| Other Income / Expenses | -0.13↓100.3% | 40↑177.2% | -52↓1063.1% | 5↑148.8% | -11 | |
| Income Before Tax | -26↓91.4% | -14↑77.3% | -60↓1471.9% | 4↑128.3% | -16 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -26↓91.4% | -14↑77.3% | -60↓1471.9% | 4↑128.3% | -16 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -26↓159.8% | -10↑83.3% | -60↓1471.9% | 4↑128.3% | -16 | |
| Bottom-Line Net Income | -26↓155.8% | -10↑83.0% | -60↓1471.9% | 4↑128.3% | -16 | |
| EPS (Basic) | -8.08↓72.6% | -4.68↓23300.0% | -0.02↓101.1% | 1.84↑111.1% | -16.50 | |
| EPS (Diluted) | -8.08↓72.6% | -4.68↓23300.0% | -0.02↓101.1% | 1.84↑111.1% | -16.50 | |
| Weighted Average Shares | 3↑13.2% | 3↓11.3% | 3↑37.9% | 2↑150.3% | 0.96 | |
| Weighted Average Diluted Shares | 3↑13.2% | 3↓11.3% | 3↑37.9% | 2↑150.3% | 0.96 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.